Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

BMC Medicine201715:55

https://doi.org/10.1186/s12916-017-0819-3

Received: 3 January 2017

Accepted: 16 February 2017

Published: 13 March 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
3 Jan 2017 Submitted Original manuscript
17 Jan 2017 Reviewed Reviewer Report - Francesco Perrone
20 Jan 2017 Reviewed Reviewer Report - Charles Butts
27 Jan 2017 Author responded Author comments - Jordi Remon
Resubmission - Version 2
27 Jan 2017 Submitted Manuscript version 2
3 Feb 2017 Reviewed Reviewer Report - Francesco Perrone
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
16 Feb 2017 Editorially accepted
13 Mar 2017 Article published 10.1186/s12916-017-0819-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cancer Medicine Department, Gustave Roussy
(2)
Medical Oncology Department, Hospital Vall d’Hebron
(3)
University Paris-Sud

Advertisement